Portfolio

Ambulero, Inc is a cell and gene therapy spin-out of the University of Miami focused on advancing new therapies to fight vascular disease. Our cell therapy program uses stromal…

Cenexum Technologies is developing the next generation of neural interfacing technology enabling wireless powered bi-directional communication with the nerve tissue for patients…

Coegin Pharma is a Nordic biotech company that, with unique technologies and competencies, focuses on the development of new pioneering treatments for diseases with a great…

Idogen develops tolerogenic cell therapies to counteract attacks by the patient’s immune system on biological agents, transplanted organs or the body’s own cells or tissue. The…

LiliumX uses protein building blocks to construct complex bispecific and multispecific biologics Our modular approach lets us freely design drug candidates with custom…

Orbit Genomics is a cancer diagnostic company developing its proprietary Orbiseq™ platform for early detection, treatment and prevention of complext diseases. The platform…

RSF Bio is a clinical stage cardiovascular therapeutics platform company based in San Diego, California. The company is developing Ataciguat: a small molecule drug developed to…

Regenesance BV (now Complement Pharma BV) is a biotech company focusing on complement inhibition to modify neurodegenerative disease progression. The Company was founded to…

RhoVac® was a pharmaceutical company dedicated to immuno-oncology, signifying that the body’s own immune system is stimulated to identify and destroy cancer cells. The primary…

RORABio is developing a first-in-class T-cell platform for targeting indications across cancer and infectious diseases. The platform consists of a newly discovered, long-lived,…